Syncthink patent
WebXinics SyncThink is a contents creation tool using a mobile device such as Android phone, iPhone and iPad. Presentation content can be produced anywhere, anytime without dependency on space and equipment. **This application is only available to a user who has received a separate account currently. WebMar 5, 2024 · The global medical devices market size was valued at $425.5 billion in 2024 and is expected to reach $612.7 billion by 2025, grow at a CAGR of 5.4%. More than …
Syncthink patent
Did you know?
Web1986-01-28 Priority to US06/823,464 priority patent/US4889422A/en 1987-01-28 Application filed by George Pavlidis filed Critical George Pavlidis 1992-07-07 Application granted granted Critical 1992-07-07 Publication of CA1304788C publication Critical patent/CA1304788C/en WebAbout SyncThink:SyncThink is on a mission to provide objective measurements for brain health and empower people to maximize their health and performance. SyncThink develops revolutionary eye tracking technology and analytics, in a VR environment, that assist medical professionals in assessing brain health, monitoring recovery and optimizing perform...
WebJan 31, 2024 · SyncThink, a leader in neurotechnology and creator of EYE-SYNC, announces today the granting of patent US 14/530,598 by the U.S. Patent and Trade Office. WebSyncThink develops revolutionary eye tracking technology and analytics, ... With more than 30 published peer-reviewed papers and 14 granted patents, the SyncThink platform uses …
WebWith GPI you can: perform regular monitoring (e.g. monthly or quarterly) of technical areas or companies to identify newly added patent documents. use the built-in charts to visualise … WebJul 20, 2024 · Sync-Think is a company that provides Medical equipment, Health care, High-speed camera and more. Sync-Think is headquartered in United States California.
WebBoston-based SyncThink said it received patent No. 9,439,592 from the U.S. Patent and Trademark Office. SyncThink hopes to innovate with improved ways to control and …
WebOct 7, 2024 · SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announced the U.S. Food and Drug Administration ... “After … diazepam na srpskomWebJun 13, 2024 · SyncThink announces that it has been granted for its EYE-SYNC brain health assessment tool. This patent, the 14th for SyncThink, is designed to allow the company … bearing 60/22duWebSync-Think is a diagnosis company. Overview; Structured Data; Issues; Contributors; Activity; Help us improve this page by adding information. bearing 60/22WebBased on 15 years of research and holding over 10 patents, SyncThink’s first product, EYE-SYNC, is a 60-second, objective sideline assessment that uses eye tracking to evaluate for … bearing 5mmWebJan 30, 2024 · SyncThink’s patent allows adapting content to a user’s interest using eye analytics. Palo Alto, CA-January 30, 2024--“With this new patent, the EYE-SYNC platform … bearing 6000 2zWebOwner: Sync-Think, Inc. Address: 54 Canal Street, Suite 200 Boston DE 02114: Legal Entity Type: Corporation: Legal Entity State: DE diazepam na srpskiWebOct 10, 2024 · RightEye, based in Bethesda, Maryland, is carving a niche in eye-tracking testing for vision impairment. Other names in the space include SyncThink, which received 510(k) clearance for its Eye-Sync device in 2016, and Neuro Kinetics, which last month gained 510(k) authorization for new features to its software for tracking a patient’s pupil. bearing 594/592